老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
HARBOR HEALTH CARE ETF
32.96
-0.3796
-1.14%
盤後：
32.96
0.0000
0.00%
16:10 EDT
成交量：
1,392
成交額：
4.61萬
市值：
4,202.99萬
市盈率：
- -
高：
33.17
開：
33.17
低：
32.95
收：
33.34
52周最高：
35.61
52周最低：
27.50
股本：
127.50萬
流通股本：
127.50萬
量比：
0.18
換手率：
0.11%
股息：
0.08
股息率：
0.23%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道
智通财经
·
08/31
不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道
智通财经
·
08/31
減重用司美格魯肽片上市申請獲受理 口服減重藥戰火燃至中國市場
每日经济新闻
·
08/31
禮來（LLY）擬以最高28.75億美元收購Merida Biosciences 加碼精準免疫療法
金吾财讯
·
08/31
Ascendis 與 BioMarin 簽署約束性條款清單，就 Yuviwel®（Navepegritide）達成全球和解及許可協議
美股速递
·
08/31
禮來：Taltz與Zepbound聯合用藥不良反應總體為輕度至中度
美股速递
·
08/31
禮來Taltz與Zepbound聯合療法新數據：一年療效顯著且持久，惠及銀屑病合併肥胖成人患者
美股速递
·
08/31
禮來公司將以28.8億美元收購梅里達生物科學公司
路透中文
·
08/31
禮來擬收購Merida Biosciences，深化嚴重自身免疫及過敏性疾病治療佈局
美股速递
·
08/31
BioMarin因與Ascendis達成全球專利和解而股價上漲
路透中文
·
08/31
拜瑪林製藥盤前股價攀升5.6%，宣佈與Ascendis Pharma達成全球和解
美股速递
·
08/31
拜瑪林製藥將撤銷ITC調查；包括多國訴訟在內的所有知識產權索賠已解決
美股速递
·
08/31
印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？
华尔街见闻
·
08/29
德意志銀行首次覆蓋Rhythm Pharmaceuticals，給予持有評級，目標價120美元
美股速递
·
08/28
美國食品藥品監督管理局（FDA）批准禮來公司的Mounjaro用於降低心血管風險
路透中文
·
08/28
FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險
美股速递
·
08/28
焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變
路透中文
·
08/28
美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑
路透中文
·
08/28
美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群
美股速递
·
08/28
兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理
智通财经
·
08/27
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/MEDI/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MEDI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","market":"US","secType":"STK","nameCN":"HARBOR HEALTH CARE ETF","latestPrice":32.9646,"timestamp":1789761600000,"preClose":33.3442,"halted":0,"volume":1392,"hourTrading":{"tag":"盘后","latestPrice":32.9646,"preClose":32.9646,"latestTime":"16:10 EDT","volume":7,"amount":230.588372,"timestamp":1789762204085,"change":0,"changeRate":0,"amplitude":0.001656},"delay":0,"changeRate":-0.011384288721876773,"floatShares":1275000,"shares":1275000,"eps":0,"marketStatus":"盤後交易","change":-0.3796,"latestTime":"09-18 17:56:47 EDT","open":33.17,"high":33.17,"low":32.95,"amount":46073,"amplitude":0.006598,"askPrice":49.53,"askSize":200,"bidPrice":16.65,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":33.3442,"sharesOutstanding":925000,"nav":33.164109,"aum":43113341.795,"dividendRate":0.00229,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.9646,"preClose":32.9646,"latestTime":"16:10 EDT","volume":7,"amount":230.588372,"timestamp":1789762204085,"change":0,"changeRate":0,"amplitude":0.001656},"volumeRatio":0.179229},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","floatShares":1275000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.179229,"shares":1275000,"dividePrice":0.0755,"high":33.17,"amplitude":0.006598,"preClose":33.3442,"low":32.95,"week52Low":27.5,"pbRate":"--","week52High":35.605,"institutionHeld":0,"latestPrice":32.9646,"committee":-0.333333,"eps":0,"divideRate":0.00229,"volume":1392,"delay":0,"ttmEps":0,"open":33.17,"prevYearClose":31.45,"prevWeekClose":33.3782,"prevMonthClose":34.24,"prevQuarterClose":33.84,"fiveDayClose":33.3782,"twentyDayClose":34.7407,"sixtyDayClose":31.8854},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDI\",params:#limit:5,,,undefined,":[{"date":"2025-12-19","symbol":"MEDI","amount":0.07515,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-24"},{"date":"2024-12-20","symbol":"MEDI","amount":0.13455,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"MEDI","amount":0.4613,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"HARBOR HEALTH CARE ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDI\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.4613,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-26","value":0.13455,"currency":"USD"},{"executeDate":"2025-12-19","recordDate":"2025-12-19","paymentDate":"2025-12-24","value":0.07515,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDI\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663006809","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006809?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FXH","NVOC","PJP","NVOH","PINK","CURE","MEDI","RSPH","IYH","NVOX","TRUH","THNR","NBDS","XLVI","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDI","NBDS","PJP","THNR","NVOX","RSPH","XLVI","CURE","NVOH","IYH","TRUH","FXH","PINK","NVOC","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663553005","title":"減重用司美格魯肽片上市申請獲受理 口服減重藥戰火燃至中國市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2663553005","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663553005?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 20:52","pubTimestamp":1788180758,"startTime":"0","endTime":"0","summary":"口服减重药物的“战火”正蔓延至中国市场。据诺和诺德方面消息，8月27日，公司递交的诺和盈片剂（司美格鲁肽片）用于长期体重管理的上市申请，已正式获得受理。在此之前，这款药物已经在美国市场展现出其商业潜力——自2026年1月上市以来，累计处方量迅速突破500万张，仅上半年即贡献销售额8.55亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860303596.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860303596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1623119135.USD","LU2265009873.SGD","LU2089283258.USD","LU2168564149.EUR","SG9999014880.SGD","OZEM","BK4581","LU0882574139.USD","PPH","LU1868837300.USD","IXJ","XLV","LU0432979614.USD","ILDR","LU0385154629.USD","IE00BKVL7J92.USD","IE00B2B36J28.USD","IE00BJLML261.HKD","LU0820561909.HKD","LU0316494557.USD","LU0320765992.SGD","LU1093756168.USD","LU2089984988.USD","LU0889565916.HKD","IE0009355771.USD","IE00B7KXQ091.USD","LU2168564495.EUR","LU0689472784.USD","LU0158827781.USD","LU1868836914.USD","LU1366192091.USD","LU0106261372.USD","LU2491050154.USD","SG9999014906.USD","LU0823416689.USD","LU2361045086.USD","LU1023059063.AUD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0154236417.USD","LU1868836591.USD","LLII","LU0198837287.USD","SG9999018857.SGD","LU2602419157.SGD","LU0323591593.USD","LU2023251221.USD","SG9999001176.SGD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU1057294990.SGD","SG9999018865.SGD","IE00BJJMRX11.SGD","IYH","LU1267930730.SGD","ELIS","LU0345770308.USD","LU1989771016.USD","LU0158827948.USD","IE00BFSS8Q28.SGD","LU0882574055.USD","LU1323610961.USD","LU0238689110.USD","LU1868837136.USD","LU2471134879.HKD","LU2756315664.SGD","SG9999013999.USD","LU1035775433.USD","LU1712237335.SGD","LU2213496289.HKD","LU2361044949.HKD","LU0203201768.USD","LU2471134523.USD","LU2471134796.USD","LU2456880835.USD","LU0417517546.SGD","LU2237443978.SGD","LLYX","IE0004445239.USD","LU2087625088.SGD","LU0210536198.USD","LU2461242641.AUD","BK4534","LU1127390331.HKD","LU0466842654.USD","GDOC","JDOC","LU0256863902.USD","LU1093756325.SGD","IHE","LU2552382215.SGD","LU2237443465.HKD","LU0320765059.SGD","LU1979441026.SGD","LU1069344957.HKD","LU1548497426.USD","TMED","LU2108987350.USD","LU2462591350.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0109394709.USD","LU2264538146.SGD","LU2417539215.USD","SGXZ57979304.SGD","BK4007","LU0006306889.USD","LU2111349929.HKD","LU2237443895.HKD","LU1720051108.HKD","IE00BFTCPJ56.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LU2168564065.EUR","PJP","LU2491050071.SGD","LU2211815571.USD","BK4516","LU1291159041.SGD","SG9999015978.USD","BK4533","LU2357305700.SGD","SGXZ81514606.USD","LU2552382132.HKD","NVO","LU2324357040.USD","LU0345770993.USD","LLY","LU2361044865.SGD","LU1629891620.HKD","LU1983299246.USD","LU2746668974.SGD","LU2236285917.USD","LU0672654240.SGD","SGXZ51526630.SGD","THNR","IE00BKDWB100.SGD","LU2756315318.SGD","LU0094547139.USD","HRTS","LU0096364046.USD","SGXZ99366536.SGD","LU0353189680.USD","BK4588","LU2471134952.CNY","FHLC","LU0708995401.HKD","LU1974910355.USD","LU1804176565.USD","LU2271345857.HKD","WDNA","SG9999001176.USD","LU2028103732.USD","MEDI","MEDX","IE00BZ1G4Q59.USD","LU0943347566.SGD","LU2168563687.JPY","SG9999015945.SGD","LU0225283273.USD","LU2896262040.SGD","IE0004445015.USD","LU0354030438.USD","LU0122379950.USD","LU0471298694.HKD","LU2023250504.SGD","GB00BDT5M118.USD","LU0353189763.USD","MHIP","LU0109391861.USD","LU0823434583.USD","LU0133085943.USD","SGXZ31699556.SGD","IE00BFSS7M15.SGD","IE00BN29S564.USD","LU0174119429.USD","NVOC","LU0456855351.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU0061475181.USD","LU0234572021.USD","LU2237443549.SGD","LU2168564222.USD","LU0640476718.USD","BK4599","LU2237438978.USD","LU2468319806.SGD","ELIL","LU0079474960.USD","LU1064131342.USD","LU2106854487.HKD","LLYZ","IE00BK4W5L77.USD","LU0354030511.USD","LU0823434740.USD","IE00B775H168.HKD","LU0683600562.USD","CURE","IE00BJJMRZ35.SGD","CANC","BK4532","FTXH","LU0787776722.HKD","LU0203202063.USD","LU1814569148.SGD","NVOX","LU0114720955.EUR","RXL","IE00B4JS1V06.HKD","LU0097036916.USD","LU2462157665.USD","SG9999014914.USD","VHT","LU1232071149.USD","LU1720051017.SGD","LU2750360997.AUD","SG9999014898.SGD","LU0964807845.USD","TRUH","LU1988902786.USD","IE0001KFT4U8.USD","LU2746668461.USD","LU1917777945.USD","LU2237443622.USD","LU1145028129.USD","LU2112291526.USD","LU0820562030.AUD","LU2491049909.HKD","LU0256863811.USD","LU0786609619.USD","SG9999015952.SGD","LU0471298777.SGD","NVOH","LU1868836757.USD","SG9999015986.USD","LU2552382058.USD","LU0058720904.USD","IE00BK4W5M84.HKD","LU2023250330.USD","LU0289739699.SGD","LU0266013472.USD","LU1551013425.SGD","LU0820561818.USD","LU2089284900.SGD","AGNG","BK4585","LU2750360641.GBP","IE0002141913.USD","LU1551013342.USD","LU2360106947.USD","SG9999017495.SGD","LU2063271972.USD","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070279","title":"禮來（LLY）擬以最高28.75億美元收購Merida Biosciences 加碼精準免疫療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070279","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070279?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:36","pubTimestamp":1788176164,"startTime":"0","endTime":"0","summary":"金吾财讯 | 制药巨头礼来公司 正式宣布，已与生物技术公司Merida Biosciences达成最终收购协议，礼来将以最高达28.75亿美元的现金进行收购，其中包括首付款以及后续基于特定里程碑进展的或有付款。Merida Biosciences专注于开发新型生物制剂，其核心技术在于通过工程化设计，选择性地清除导致免疫介导疾病的致病性自身抗体，同时保留人体正常的免疫功能。本次收购的重点资产为其核心候选药物MER511。目前，MER511正在针对格雷夫斯病和甲状腺眼病展开1期临床试验。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305494","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU0203201768.USD","LU1917777945.USD","IE0005OL40V9.USD","IE00BFSS8Q28.SGD","LU2237443622.USD","LU1057294990.SGD","IE00B7KXQ091.USD","LU0210536198.USD","TMED","LU0203202063.USD","LU2111349929.HKD","LU2236285917.USD","SG9999001176.USD","IE0001KFT4U8.USD","LU1127390331.HKD","IE00B775H168.HKD","LU1069344957.HKD","LU1691799644.USD","LU1974910355.USD","LU0234572021.USD","LU2491049909.HKD","LU0345770993.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU0471298694.HKD","LU2471134796.USD","LU2271345857.HKD","IE00BKPKM429.USD","ELIS","LU1035775433.USD","LU1989771016.USD","LU1291159041.SGD","LU2360106947.USD","IE00B2B36J28.USD","LU0256863811.USD","LU2264538146.SGD","IE00BN29S564.USD","LU1267930730.SGD","LU1145028129.USD","IE00BK4W5L77.USD","BK4534","SG9999013999.USD","JDOC","LU1551013425.SGD","IE0009355771.USD","LU2756315664.SGD","LU2750360997.AUD","LU2491050154.USD","LU2168564065.EUR","LU0320765992.SGD","LU2237443549.SGD","LU2471134523.USD","SG9999015952.SGD","SG9999018865.SGD","SG9999015978.USD","BK4516","ILDR","LU2552382215.SGD","LU2417539215.USD","LLY","LU0158827781.USD","LU0320765059.SGD","THNR","LU0058720904.USD","IE00BFSS7M15.SGD","LU1868837136.USD","LU0820561909.HKD","IYH","IXJ","LU0353189763.USD","LU1323610961.USD","LU1804176565.USD","LU2023250330.USD","LU2756315318.SGD","LU1720051017.SGD","LU0787776722.HKD","LU1712237335.SGD","LU0006306889.USD","LU2468319806.SGD","LU2265009873.SGD","LU1623119135.USD","LU1366192091.USD","LU0354030511.USD","LU0672654240.SGD","IE00BJT1NW94.SGD","LU2237443978.SGD","LU0256863902.USD","LU0823416689.USD","LU0882574139.USD","LU2168564495.EUR","LU2602419157.SGD","LLII","LU1720051108.HKD","LU0238689110.USD","LU1232071149.USD","IE00BJLML261.HKD","AGNG","LU2746668461.USD","LU2462591350.SGD","RXL","LU0466842654.USD","LU0345770308.USD","LU0820562030.AUD","LU1868836591.USD","LU1551013342.USD","LU2746668974.SGD","LU2089283258.USD","BK4007","LU2106854487.HKD","LU2168563687.JPY","LU0417517546.SGD","LU0882574055.USD","IE00B4R5TH58.HKD","LU2237443382.USD","HRTS","LU0683600562.USD","LU1093756325.SGD","LU2552382058.USD","IE00BFTCPJ56.SGD","LU1548497426.USD","CANC","LU2361044865.SGD","LU0820561818.USD","LU2063271972.USD","LU0456855351.SGD","BK4533","ELIL","BK4588","IHE","LU0133085943.USD","LU1979441026.SGD","LU1868837300.USD","LU2023250504.SGD","LU2357305700.SGD","LU2456880835.USD","LU2361045086.USD","LU2462157665.USD","SG9999014898.SGD","LU0471298777.SGD","LLYX","LU0158827948.USD","SG9999017495.SGD","LU2028103732.USD","LU2361044949.HKD","WDNA","LU0385154629.USD","LU0353189680.USD","SG9999014906.USD","LU2112291526.USD","LU0289739699.SGD","LLYZ","LU0943347566.SGD","IE0004445239.USD","LU0689472784.USD","LU0432979614.USD","LU0786609619.USD","LU0114720955.EUR","LU0889565916.HKD","LU2896262040.SGD","LU0096364046.USD","LU0174119429.USD","LU0198837287.USD","LU0708995401.HKD","GB00BDT5M118.USD","BK4581","IE0002141913.USD","LU0964807845.USD","LU2108987350.USD","LU2168564149.EUR","LU2552382132.HKD","MEDI","SGXZ31699556.SGD","SGXZ81514606.USD","LU0266013472.USD","GDOC","LU2237443465.HKD","FHLC","IE00B1BXHZ80.USD","LU0323591593.USD","CURE","SG9999018857.SGD","LU2324357040.USD","LU1868836757.USD","LU1988902786.USD","LU0122379950.USD","LU2750360641.GBP","PJP","LU2461242641.AUD","LU0109391861.USD","LU2471134879.HKD","LU0097036916.USD","LU2023251221.USD","LU2089284900.SGD","IE00B4JS1V06.HKD","LU1093756168.USD","LU2168564222.USD","BK4585","LU2237443895.HKD","LU2087625088.SGD","OZEM","IE00BK4W5M84.HKD","SG9999015986.USD","LU0316494557.USD","LU0640476718.USD","LU1629891620.HKD","BK4599","LU2471134952.CNY","IE0004445015.USD","IE00B1XK9C88.USD","LU0061475181.USD","PPH","SGXZ51526630.SGD","TRUH","IE00BKDWB100.SGD","XLV","IE00BJJMRY28.SGD","LU1814569148.SGD","SG9999014914.USD","SGXZ57979304.SGD","LU2211815571.USD","VHT","LU1280957306.USD","LU1868836914.USD","LU0106261372.USD","SG9999001176.SGD","SGXZ99366536.SGD","LU1023059063.AUD","SG9999015945.SGD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU2491050071.SGD","FTXH","LU2237438978.USD","LU0225283273.USD","LU0354030438.USD","LU0094547139.USD","LU0109394709.USD","LU0823434740.USD","LU1061106388.HKD","LU2089984988.USD","LU2213496289.HKD","MEDX","SG9999014880.SGD","LU1983299246.USD","LU1064131342.USD","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168094828","title":"Ascendis 與 BioMarin 簽署約束性條款清單，就 Yuviwel®（Navepegritide）達成全球和解及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1168094828","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168094828?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:03","pubTimestamp":1788174216,"startTime":"0","endTime":"0","summary":"Ascendis 与 BioMarin 宣布，双方已正式签署一份具有约束力的条款清单，旨在于全球范围内就 Yuviwel®（Navepegritide）相关事宜达成全面和解与许可安排。此举标志着两家公司围绕该产品展开的长期纠纷或合作谈判进入关键性的实质性阶段，为后续正式协议的最终落地奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","MEDI","LU0889565916.HKD","BK4585","BK4139","LU0109394709.USD","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117495953","title":"禮來：Taltz與Zepbound聯合用藥不良反應總體為輕度至中度","url":"https://stock-news.laohu8.com/highlight/detail?id=1117495953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117495953?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:03","pubTimestamp":1788174182,"startTime":"0","endTime":"0","summary":"礼来（Eli Lilly）披露，在同时接受Taltz与Zepbound治疗的患者中，所观察到的不良事件大体上属于轻度至中度范畴。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1551013342.USD","LU0786609619.USD","LU2023250504.SGD","LU2552382132.HKD","LU0787776722.HKD","IE00BWXC8680.SGD","LU2471134952.CNY","LU0106261372.USD","WDNA","BK4585","LU1366192091.USD","LU2552382215.SGD","LU1868837136.USD","GDOC","FTXH","SG9999017495.SGD","LU0640476718.USD","LU1804176565.USD","LU2236285917.USD","LU0122379950.USD","BK4534","FHLC","LU2023251221.USD","LU0094547139.USD","LU2462157665.USD","IE00B775H168.HKD","LU1814569148.SGD","LU2063271972.USD","LU0889565916.HKD","LU2237443549.SGD","LU0320765992.SGD","LU0114720955.EUR","LU2746668461.USD","LU2471134879.HKD","IE0009355771.USD","IE00B1BXHZ80.USD","LU1868836914.USD","LU2237443978.SGD","LU0079474960.USD","LU2108987350.USD","BK4007","IXJ","LU0109394709.USD","IE00BK4W5M84.HKD","LU0354030511.USD","LU1064131342.USD","LU0316494557.USD","LU2211815571.USD","LU1917777945.USD","LU2237443895.HKD","MEDI","LU1988902786.USD","OZEM","SG9999015952.SGD","THNR","ILDR","LU1979441026.SGD","TRUH","LU0234572021.USD","LU2360106947.USD","SG9999013999.USD","LU1057294990.SGD","LU2168564149.EUR","SG9999001176.SGD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","LU1974910355.USD","JDOC","IE00BJJMRX11.SGD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","LU1145028129.USD","LU0058720904.USD","LU2264538146.SGD","LLII","LU2112291526.USD","IHE","LU0256863811.USD","LU2271345857.HKD","SG9999014914.USD","PJP","CURE","MHIP","LU0385154629.USD","LU1061106388.HKD","LU0266013472.USD","LU1551013425.SGD","LU0683600562.USD","LU1691799644.USD","LU2361044865.SGD","IE00B1XK9C88.USD","RXL","LU0823434740.USD","LU0672654240.SGD","LU0943347566.SGD","LU1267930730.SGD","LU2461242641.AUD","LU1720051017.SGD","LLY","LU2361044949.HKD","LU1093756168.USD","LLYX","LU2213496289.HKD","LU2552382058.USD","LU0708995401.HKD","IE00BKDWB100.SGD","IE00BJLML261.HKD","LU0158827781.USD","IE0002141913.USD","LU2456880835.USD","IE00B7KXQ091.USD","LU2168564222.USD","SG9999018865.SGD","LU1983299246.USD","BK4533","LU0471298694.HKD","LU0882574139.USD","LU0061475181.USD","IE00BK4W5L77.USD","LU0096364046.USD","LU0882574055.USD","IE0001KFT4U8.USD","LLYZ","LU0323591593.USD","LU1093756325.SGD","LU1712237335.SGD","ELIL","LU1023059063.AUD","LU2265009873.SGD","LU0238689110.USD","LU0471298777.SGD","CANC","IE00B2B36J28.USD","LU0432979614.USD","ELIS","LU0353189680.USD","LU2168563687.JPY","LU2602419157.SGD","LU0320765059.SGD","LU0820561818.USD","LU2237443382.USD","LU2237443465.HKD","SG9999015945.SGD","SGXZ51526630.SGD","IE0004445015.USD","LU0225283273.USD","LU2324357040.USD","LU0345770308.USD","BK4516","LU1232071149.USD","LU2111349929.HKD","LU0820562030.AUD","LU2168564495.EUR","LU1868836757.USD","LU2756315664.SGD","LU0210536198.USD","LU0354030438.USD","LU0198837287.USD","SG9999018857.SGD","PPH","LU1629891620.HKD","LU2237438978.USD","LU2361045086.USD","LU0466842654.USD","LU2468319806.SGD","IE00BFSS7M15.SGD","LU1323610961.USD","LU0345770993.USD","SG9999001176.USD","SG9999014880.SGD","LU0158827948.USD","LU2491049909.HKD","LU2089984988.USD","BK4599","LU1291159041.SGD","LU2491050071.SGD","IYH","LU0689472784.USD","LU2417539215.USD","IE00BFSS8Q28.SGD","LU0203202063.USD","LU2750360641.GBP","LU2462591350.SGD","LU0823416689.USD","LU0289739699.SGD","GB00BDT5M118.USD","LU2357305700.SGD","LU0964807845.USD","SG9999015978.USD","BK4581","AGNG","TMED","LU1127390331.HKD","LU0203201768.USD","LU0820561909.HKD","LU0006306889.USD","LU2471134523.USD","LU1623119135.USD","LU2087625088.SGD","SG9999014898.SGD","LU2896262040.SGD","IE00BJJMRY28.SGD","LU0133085943.USD","LU2491050154.USD","LU2750360997.AUD","HRTS","LU1548497426.USD","LU1868837300.USD","LU1035775433.USD","LU2756315318.SGD","LU1280957306.USD","MEDX","SGXZ81514606.USD","LU2237443622.USD","BK4588","LU0353189763.USD","LU2168564065.EUR","LU2089283258.USD","LU0174119429.USD","SG9999015986.USD","LU2023250330.USD","SGXZ57979304.SGD","IE0004445239.USD","LU2089284900.SGD","IE00BJJMRZ35.SGD","SG9999014906.USD","IE00B4R5TH58.HKD","IE00BN29S564.USD","LU1720051108.HKD","LU2028103732.USD","XLV","LU0256863902.USD","IE00B4JS1V06.HKD","LU0109391861.USD","LU2106854487.HKD","LU1069344957.HKD","SGXZ99366536.SGD","LU0417517546.SGD","LU2746668974.SGD","VHT","LU1989771016.USD","LU1868836591.USD","LU0823434583.USD","LU2471134796.USD","IE0005OL40V9.USD","LU0097036916.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154910104","title":"禮來Taltz與Zepbound聯合療法新數據：一年療效顯著且持久，惠及銀屑病合併肥胖成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1154910104","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154910104?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:01","pubTimestamp":1788174110,"startTime":"0","endTime":"0","summary":"制药巨头礼来公司近日披露了其两款重磅药物联合使用的全新数据。这项名为3B期的临床研究成果，聚焦于Taltz与Zepbound的组合方案。研究显示，对于同时患有银屑病及肥胖症的成年患者，该联合疗法在为期一年的治疗周期内，展现出了颇为显著且令人鼓舞的疗效提升。礼来公司表示，此次公布的数据将进一步支持Taltz与Zepbound联合用药在特定患者群中的潜在应用价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1720051017.SGD","JDOC","SG9999001176.SGD","LU2237443465.HKD","LU0471298777.SGD","PJP","SG9999017495.SGD","LU0943347566.SGD","SG9999014898.SGD","LU0158827781.USD","IE00BKDWB100.SGD","LU2491049909.HKD","LU1868837300.USD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LU2750360641.GBP","FHLC","LU2271345857.HKD","LLII","LU1814569148.SGD","LU2089284900.SGD","LU0672654240.SGD","RXL","LU0316494557.USD","IE00BFSS8Q28.SGD","LU0061475181.USD","HRTS","IE00B4JS1V06.HKD","IE00B4R5TH58.HKD","MHIP","SGXZ81514606.USD","SG9999015978.USD","LU2237443549.SGD","GB00BDT5M118.USD","LU2168563687.JPY","LU0096364046.USD","LU2211815571.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","LU2087625088.SGD","TRUH","LU0106261372.USD","LU1035775433.USD","LU1868836757.USD","LU1979441026.SGD","SG9999001176.USD","LU0114720955.EUR","LU1983299246.USD","LU1061106388.HKD","LU2108987350.USD","IE0005OL40V9.USD","LU0225283273.USD","MEDI","LU2552382132.HKD","IE00BK4W5M84.HKD","TMED","LU0198837287.USD","LU1868836914.USD","LU2237443622.USD","SG9999015945.SGD","SG9999018865.SGD","LU2237443382.USD","LU1712237335.SGD","LU1551013425.SGD","LU0823434583.USD","LU0122379950.USD","LU2213496289.HKD","BK4599","LU2462591350.SGD","LU0203201768.USD","IE00BK4W5L77.USD","SGXZ57979304.SGD","LU2361045086.USD","LU1064131342.USD","LU0471298694.HKD","LU2168564495.EUR","LU2023250330.USD","LU1917777945.USD","CANC","SG9999015952.SGD","LU0787776722.HKD","SG9999014914.USD","LU1629891620.HKD","LU1868836591.USD","IE00BJT1NW94.SGD","IE0004445015.USD","LU1145028129.USD","LU0823416689.USD","LU2417539215.USD","LU1280957306.USD","LU2324357040.USD","LU0158827948.USD","LU0345770993.USD","IE00B775H168.HKD","LU2602419157.SGD","LU0174119429.USD","LU0238689110.USD","FTXH","LU1267930730.SGD","LU2089283258.USD","LU2237438978.USD","LU2168564065.EUR","IE00BN29S564.USD","LU2471134952.CNY","LU2552382058.USD","LU0385154629.USD","LU2746668974.SGD","LU0689472784.USD","LU2491050154.USD","SGXZ99366536.SGD","XLV","LU1623119135.USD","LU0354030438.USD","IE00BJJMRY28.SGD","LU2361044865.SGD","LU2106854487.HKD","LU0079474960.USD","THNR","BK4007","LU0345770308.USD","LU0256863811.USD","LU0683600562.USD","LU0109394709.USD","LU0353189763.USD","LU1093756168.USD","LU1366192091.USD","IE00BFSS7M15.SGD","LU0203202063.USD","SG9999013999.USD","IE00B2B36J28.USD","LU1023059063.AUD","ELIS","LU2552382215.SGD","IE00B1XK9C88.USD","LU2756315664.SGD","LU0882574055.USD","LU1291159041.SGD","LU2468319806.SGD","LU0097036916.USD","LU0964807845.USD","LU0820561909.HKD","SGXZ31699556.SGD","IHE","BK4533","LU2756315318.SGD","LU2471134879.HKD","LU1868837136.USD","LU1804176565.USD","LU0786609619.USD","WDNA","LU2491050071.SGD","CURE","LU2360106947.USD","LU0058720904.USD","LU2063271972.USD","LU2089984988.USD","IXJ","BK4534","LU0289739699.SGD","LU1057294990.SGD","LU0006306889.USD","IE0004445239.USD","LU1548497426.USD","LU2111349929.HKD","PPH","LLYX","LU0353189680.USD","LU0323591593.USD","LU0640476718.USD","OZEM","SG9999014906.USD","IE00BJJMRX11.SGD","LU0708995401.HKD","LU0210536198.USD","LU0256863902.USD","LU1691799644.USD","LU1093756325.SGD","LU1127390331.HKD","LU0234572021.USD","SG9999014880.SGD","LU2456880835.USD","IE00BWXC8680.SGD","LU2462157665.USD","LU1551013342.USD","IE00BJJMRZ35.SGD","LU2168564222.USD","LU1069344957.HKD","LU1974910355.USD","LU2237443978.SGD","SG9999018857.SGD","IYH","LU2471134796.USD","LU0417517546.SGD","LU2357305700.SGD","LU2361044949.HKD","LU2237443895.HKD","LU2750360997.AUD","AGNG","BK4516","LU2746668461.USD","LU2028103732.USD","LU0466842654.USD","ILDR","LU0432979614.USD","LU2264538146.SGD","LU2265009873.SGD","SGXZ51526630.SGD","ELIL","LU2023251221.USD","LU1989771016.USD","VHT","IE00BKPKM429.USD","IE0009355771.USD","LU0320765059.SGD","LU0889565916.HKD","LU0456855351.SGD","BK4588","LU1988902786.USD","LU0109391861.USD","LU0820561818.USD","LU1720051108.HKD","LU2896262040.SGD","LU2471134523.USD","LU2236285917.USD","LU1323610961.USD","SG9999015986.USD","LU0094547139.USD","LU0823434740.USD","GDOC","LU1232071149.USD","LU2023250504.SGD","LU0133085943.USD","LU2461242641.AUD","MEDX","IE00BFTCPJ56.SGD","LU0354030511.USD","LU0882574139.USD","BK4585","LU0820562030.AUD","IE0002141913.USD","LLY","IE0001KFT4U8.USD","LLYZ","LU2168564149.EUR","LU0266013472.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663133072","title":"禮來公司將以28.8億美元收購梅里達生物科學公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2663133072","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663133072?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:51","pubTimestamp":1788173505,"startTime":"0","endTime":"0","summary":"礼来公司将以28.8亿美元收购梅里达生物科学公司路透8月31日-礼来公司（Eli Lilly，LLY.N）周一表示，将以最高28.8亿美元的现金收购私营企业梅里达生物科学公司（Merida Biosciences），以此扩大其在免疫相关疾病和过敏性疾病治疗药物研发方面的布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4S44S0TE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU0471298777.SGD","LU0882574055.USD","MHIP","LU2237443549.SGD","LU2417539215.USD","LU2756315664.SGD","LU2108987350.USD","LU2491049909.HKD","LU2023251221.USD","LU1035775433.USD","IE00BFSS7M15.SGD","LU0345770993.USD","LU0353189763.USD","LU0823434740.USD","LU0256863811.USD","LU1988902786.USD","LU2168564495.EUR","LU2265009873.SGD","LU1366192091.USD","IE0004445239.USD","LU0058720904.USD","IE00BK4W5L77.USD","LU1917777945.USD","IE00B4R5TH58.HKD","LU1720051017.SGD","SG9999017495.SGD","BK4599","ELIS","IE00B775H168.HKD","LU1323610961.USD","IE00BKDWB100.SGD","LU0417517546.SGD","LU2468319806.SGD","LU1868837136.USD","LU2168564065.EUR","LU0122379950.USD","MEDX","LU2106854487.HKD","LU2237443465.HKD","SG9999018865.SGD","LU0198837287.USD","LU0109394709.USD","LU0210536198.USD","LU2089284900.SGD","LU0385154629.USD","LU0158827781.USD","LU2357305700.SGD","LU0708995401.HKD","LU1061106388.HKD","LLYX","LU0158827948.USD","LU0266013472.USD","LU2746668461.USD","LU1145028129.USD","IE0001KFT4U8.USD","MEDI","LU2237443978.SGD","LU2361044865.SGD","LU1868836914.USD","IE00B1XK9C88.USD","LU0097036916.USD","IE0009355771.USD","AGNG","LU0323591593.USD","SG9999014880.SGD","LU0640476718.USD","LU0820561909.HKD","LU0289739699.SGD","LU2750360997.AUD","LU0320765992.SGD","SG9999015986.USD","LU0672654240.SGD","LU0061475181.USD","IE00BFSS8Q28.SGD","LU0096364046.USD","LU1267930730.SGD","TMED","LU1720051108.HKD","BK4516","SG9999001176.USD","LU0203201768.USD","LU0432979614.USD","IE0004445015.USD","LU2063271972.USD","IHE","LU0353189680.USD","LU0354030511.USD","SG9999001176.SGD","XLV","LU0345770308.USD","LU1623119135.USD","LU2361045086.USD","LU0471298694.HKD","IE00BN29S564.USD","LU2237443382.USD","SG9999014898.SGD","LU1804176565.USD","LU2360106947.USD","LLY","SGXZ81514606.USD","LU1291159041.SGD","LU2491050071.SGD","LU2456880835.USD","LU2552382058.USD","LU0079474960.USD","LU2087625088.SGD","SGXZ99366536.SGD","LU2237438978.USD","IE00BKPKM429.USD","LU1629891620.HKD","LU0320765059.SGD","SG9999015978.USD","LU0316494557.USD","LU1989771016.USD","LU0786609619.USD","LLYZ","LU2471134952.CNY","LU0466842654.USD","BK4007","IE00BJJMRX11.SGD","IE0005OL40V9.USD","IE0002141913.USD","SG9999014914.USD","LU1974910355.USD","SG9999018857.SGD","LU2361044949.HKD","LU2552382215.SGD","OZEM","SG9999015952.SGD","LU2028103732.USD","ELIL","SGXZ57979304.SGD","BK4585","LU1064131342.USD","LU1069344957.HKD","LU1057294990.SGD","LU2213496289.HKD","TRUH","LU0456855351.SGD","LU0234572021.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU0882574139.USD","LU2491050154.USD","LU0114720955.EUR","LU2471134796.USD","LU1548497426.USD","LU0889565916.HKD","LU0006306889.USD","ILDR","LU0823416689.USD","LU2461242641.AUD","VHT","LU2471134523.USD","IE00BJJMRY28.SGD","IE00B4JS1V06.HKD","LU2746668974.SGD","LU2552382132.HKD","LU0683600562.USD","LU0787776722.HKD","LU2023250504.SGD","IYH","LU2271345857.HKD","LU0943347566.SGD","LU0174119429.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU0820561818.USD","LU2236285917.USD","LU1551013342.USD","LU1712237335.SGD","LU2756315318.SGD","LU0820562030.AUD","RXL","PPH","LU0094547139.USD","LU0109391861.USD","LU1280957306.USD","LU1868836591.USD","HRTS","LU1023059063.AUD","FHLC","IE00BWXC8680.SGD","LU2089283258.USD","BK4533","JDOC","SG9999014906.USD","BK4581","LU2168564222.USD","LU2264538146.SGD","FTXH","LU1691799644.USD","SG9999013999.USD","LU2896262040.SGD","THNR","LU2211815571.USD","LU2237443895.HKD","LU2462157665.USD","LU0823434583.USD","GDOC","LU2023250330.USD","LU1868836757.USD","PJP","LU0256863902.USD","CURE","IE00B7KXQ091.USD","LU0133085943.USD","SGXZ31699556.SGD","LU1979441026.SGD","LU0225283273.USD","LU2237443622.USD","LU0238689110.USD","CANC","LU0106261372.USD","LU2089984988.USD","GB00BDT5M118.USD","WDNA","BK4588","IE00BJT1NW94.SGD","IE00BJLML261.HKD","LU1093756168.USD","IE00B1BXHZ80.USD","LU0203202063.USD","LU1232071149.USD","LU1814569148.SGD","LU1127390331.HKD","LU2112291526.USD","LU1868837300.USD","SG9999015945.SGD","IE00B2B36J28.USD","LU2602419157.SGD","LU2471134879.HKD","LU0964807845.USD","LU2462591350.SGD","LU2111349929.HKD","IE00BJJMRZ35.SGD","BK4534","LLII","LU0354030438.USD","LU1093756325.SGD","LU2168564149.EUR","IXJ","LU2168563687.JPY","LU2324357040.USD","LU1983299246.USD","IE00BK4W5M84.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171558090","title":"禮來擬收購Merida Biosciences，深化嚴重自身免疫及過敏性疾病治療佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1171558090","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171558090?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:46","pubTimestamp":1788173192,"startTime":"0","endTime":"0","summary":"礼来公司宣布，将收购Merida Biosciences，此举旨在进一步推进针对严重自身免疫性疾病和过敏性疾病的治疗方案研发。这一战略动作，标志着礼来在生物制药领域，尤其是在未被满足的医疗需求方面，正加速其布局与投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2211815571.USD","LU2746668461.USD","LU2750360997.AUD","LU0289739699.SGD","IE00BWXC8680.SGD","LU0689472784.USD","LU0823416689.USD","SG9999015952.SGD","SGXZ81514606.USD","LU0354030511.USD","LU2357305700.SGD","LU0820562030.AUD","LU2471134796.USD","IE0001KFT4U8.USD","ELIL","LU0058720904.USD","LU2168563687.JPY","LU0266013472.USD","LU0456855351.SGD","IE00B7KXQ091.USD","LU0133085943.USD","LU2213496289.HKD","LU2456880835.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU2237438978.USD","LU0882574055.USD","LU2237443549.SGD","LU0787776722.HKD","LU0823434740.USD","LU1917777945.USD","MEDX","LU1280957306.USD","VHT","LU1979441026.SGD","PPH","IXJ","LU0882574139.USD","IE00BKDWB100.SGD","LU1267930730.SGD","LU1145028129.USD","LU2552382132.HKD","LU0320765992.SGD","IE00BN29S564.USD","LU0079474960.USD","LU2462157665.USD","LU2265009873.SGD","SGXZ57979304.SGD","LU1868836591.USD","LU1804176565.USD","LU2237443978.SGD","JDOC","LU2896262040.SGD","LU2417539215.USD","IE00BFSS7M15.SGD","THNR","LU0109391861.USD","SG9999014880.SGD","SGXZ51526630.SGD","LU1712237335.SGD","LU2111349929.HKD","TMED","LU1069344957.HKD","RXL","LU0943347566.SGD","LU0122379950.USD","LU0316494557.USD","IE00B1XK9C88.USD","LU1623119135.USD","LU2361045086.USD","LU1551013425.SGD","LU0256863811.USD","SG9999001176.SGD","SG9999015978.USD","LU2756315664.SGD","LU1023059063.AUD","LU1057294990.SGD","SGXZ31699556.SGD","LU1814569148.SGD","BK4516","LLY","LU1093756325.SGD","LU1974910355.USD","PJP","IE0005OL40V9.USD","IE0009355771.USD","LU0471298777.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU0353189680.USD","LU1291159041.SGD","LU0823434583.USD","LU1868836757.USD","LU1720051108.HKD","LU2023250330.USD","LU2168564495.EUR","SGXZ99366536.SGD","IE00BJT1NW94.SGD","MHIP","LU0889565916.HKD","LU2108987350.USD","LU2468319806.SGD","LU0345770993.USD","LU0097036916.USD","LU2106854487.HKD","LU0114720955.EUR","LU2237443622.USD","LU2237443895.HKD","LU2361044865.SGD","LU2552382058.USD","IE00B4JS1V06.HKD","FTXH","LU1868837136.USD","BK4534","LU0158827781.USD","LU0094547139.USD","BK4533","LU1323610961.USD","BK4581","SG9999014898.SGD","LU2089284900.SGD","WDNA","LU2471134952.CNY","LU0672654240.SGD","LU2112291526.USD","LU2237443382.USD","LU0964807845.USD","XLV","SG9999001176.USD","LLYZ","LLII","IE00BJLML261.HKD","IE00BJJMRY28.SGD","LU2361044949.HKD","LU0417517546.SGD","LU0385154629.USD","TRUH","LU2168564222.USD","IYH","LU0345770308.USD","LU0096364046.USD","LU1691799644.USD","LU0471298694.HKD","IE0004445239.USD","LLYX","LU0466842654.USD","LU2264538146.SGD","LU1868837300.USD","LU0354030438.USD","LU2271345857.HKD","LU2087625088.SGD","LU0174119429.USD","LU2471134523.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0708995401.HKD","HRTS","SG9999018865.SGD","OZEM","LU2023251221.USD","LU0640476718.USD","LU0683600562.USD","LU1629891620.HKD","LU0353189763.USD","LU1983299246.USD","SG9999017495.SGD","SG9999014906.USD","IE00B775H168.HKD","LU1093756168.USD","IHE","IE00BJJMRX11.SGD","LU2324357040.USD","LU1868836914.USD","LU1989771016.USD","LU0225283273.USD","LU2471134879.HKD","LU2756315318.SGD","LU2462591350.SGD","LU1548497426.USD","ELIS","IE0004445015.USD","LU0061475181.USD","LU1035775433.USD","LU2491050154.USD","LU2746668974.SGD","SG9999018857.SGD","CANC","FHLC","IE00BK4W5M84.HKD","LU2089283258.USD","LU0320765059.SGD","SG9999014914.USD","BK4588","LU0234572021.USD","BK4599","LU0432979614.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU0820561909.HKD","LU0323591593.USD","LU1232071149.USD","LU2461242641.AUD","LU0109394709.USD","LU2063271972.USD","IE00BKPKM429.USD","IE00B2B36J28.USD","LU0203201768.USD","LU1988902786.USD","LU2602419157.SGD","LU0106261372.USD","LU2237443465.HKD","LU2552382215.SGD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0006306889.USD","CURE","IE00BJJMRZ35.SGD","LU2750360641.GBP","LU1061106388.HKD","AGNG","LU2360106947.USD","SG9999013999.USD","LU1127390331.HKD","LU0198837287.USD","LU0238689110.USD","LU1366192091.USD","LU2028103732.USD","LU2168564149.EUR","LU0820561818.USD","BK4585","LU0210536198.USD","LU0786609619.USD","GDOC","BK4007","IE0002141913.USD","MEDI","ILDR","LU2023250504.SGD","LU2491050071.SGD","LU1720051017.SGD","LU2236285917.USD","GB00BDT5M118.USD","LU2089984988.USD","LU0158827948.USD","LU2168564065.EUR","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076911","title":"BioMarin因與Ascendis達成全球專利和解而股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076911","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076911?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:14","pubTimestamp":1788167653,"startTime":"0","endTime":"0","summary":"BUZZ-BioMarin因与Ascendis达成全球专利和解而股价上涨8月31日-** 制药公司BioMarin Pharmaceutical（BMRN.O）的股价在盘前交易中上涨5.9%，至68.48美元** BioMarin与Ascendis Pharma（ASND.O）就Ascendis的生长障碍药物Yuviwel所涉的所有专利纠纷达成和解（(link)）** Ascendis将从该药物首","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S0N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","ASND","BK4585","MEDI","IE00B19Z3581.USD","IE0002270589.USD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BMRN","BK4566","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152003599","title":"拜瑪林製藥盤前股價攀升5.6%，宣佈與Ascendis Pharma達成全球和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1152003599","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152003599?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 16:38","pubTimestamp":1788165495,"startTime":"0","endTime":"0","summary":"拜玛林制药（Biomarin Pharmaceutical）的股价在盘前交易时段上扬5.6%。这一涨幅源于公司宣布已与Ascendis Pharma达成全球和解协议。市场对这一消息反应积极，推动股价走强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","MEDI","LU0109394709.USD","BK4566","ASND","LU0889565916.HKD","LU0320765992.SGD","BK4139","BK4585","IE00B7SZLL34.SGD","IE0002270589.USD","BMRN","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172567405","title":"拜瑪林製藥將撤銷ITC調查；包括多國訴訟在內的所有知識產權索賠已解決","url":"https://stock-news.laohu8.com/highlight/detail?id=1172567405","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172567405?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:02","pubTimestamp":1788156130,"startTime":"0","endTime":"0","summary":"拜玛林制药宣布，将撤销美国国际贸易委员会（ITC）的调查。该公司表示，所有知识产权相关主张均已得到解决，其中涵盖了在多个国家进行的诉讼。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0109394709.USD","MEDI","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4585","IE00B7SZLL34.SGD","ASND","IE00B19Z3581.USD","BMRN","LU0320765992.SGD","BK4139","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663168590","title":"印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？","url":"https://stock-news.laohu8.com/highlight/detail?id=2663168590","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663168590?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 05:55","pubTimestamp":1787954138,"startTime":"0","endTime":"0","summary":"印度减肥药市场正在给全球制药行业上一堂关于市场预期的警示课。尽管GLP-1类药物在印度已实现大规模仿制、价格降至每月14美元，销售表现却远逊于预期，揭示出价格之外更深层的文化、社会与监管障碍。截至今年7月，约三十余种仿制GLP-1药物已在印度药房上市。市场冷淡直接冲击了制药行业对印度的增长押注。印度市场本被视为GLP-1药物向美欧以外拓展的重要试验场。","market":"nz","thumbnail":"https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3780608","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","MEDI","ELIL","FXH","LLII","JDOC","PJP","OZEM","NVOH","ELIS","THNR","NVOC","NBDS","UUP","UDN","PINK","CURE","IYH","LLYX","XLVI","RSPH","TRUH","MNDmain","NVOX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1181502048","title":"德意志銀行首次覆蓋Rhythm Pharmaceuticals，給予持有評級，目標價120美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181502048","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181502048?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:10","pubTimestamp":1787915412,"startTime":"0","endTime":"0","summary":"德意志银行宣布，首次对Rhythm Pharmaceuticals展开覆盖研究。该行给予这家制药公司\"持有\"评级，并将目标股价设定在每股120美元。这一动作，为市场参与者提供了新的分析视角。在生物制药领域，投资机构的态度往往具有风向标意义。Rhythm Pharmaceuticals未来的股价走势，是否会朝着120美元的目标价位靠拢，值得投资者持续关注。德意志银行此次给出的评级，既不悲观亦非强烈看多，反映出一种中性的市场预期。这一决策背后，或许暗含着对该公司现有产品线及在研管线的综合评估。市场对此举的反应，尚待观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","MEDI","RYTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662608062","title":"美國食品藥品監督管理局（FDA）批准禮來公司的Mounjaro用於降低心血管風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2662608062","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662608062?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:05","pubTimestamp":1787915151,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准礼来公司的Mounjaro用于降低心血管风险路透8月28日-礼来公司（LLY.N）周五表示，美国食品药品监督管理局（FDA）已批准其糖尿病药物Mounjaro，用于降低患有2型糖尿病且发生重大心血管不良事件风险较高的成年患者的该类事件风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2211815571.USD","LU2746668461.USD","LU2750360997.AUD","LU0289739699.SGD","IE00BWXC8680.SGD","LU0689472784.USD","LU0823416689.USD","SG9999015952.SGD","SGXZ81514606.USD","LU0354030511.USD","LU2357305700.SGD","LU0820562030.AUD","LU2471134796.USD","IE0001KFT4U8.USD","ELIL","LU0058720904.USD","LU2168563687.JPY","LU0266013472.USD","LU0456855351.SGD","IE00B7KXQ091.USD","LU0133085943.USD","LU2213496289.HKD","LU2456880835.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU2237438978.USD","LU0882574055.USD","LU2237443549.SGD","LU0787776722.HKD","LU0823434740.USD","LU1917777945.USD","MEDX","LU1280957306.USD","VHT","LU1979441026.SGD","PPH","IXJ","LU0882574139.USD","IE00BKDWB100.SGD","LU1267930730.SGD","LU1145028129.USD","LU2552382132.HKD","LU0320765992.SGD","IE00BN29S564.USD","LU0079474960.USD","LU2462157665.USD","LU2265009873.SGD","SGXZ57979304.SGD","LU1868836591.USD","LU1804176565.USD","LU2237443978.SGD","JDOC","LU2896262040.SGD","LU2417539215.USD","IE00BFSS7M15.SGD","THNR","LU0109391861.USD","SG9999014880.SGD","SGXZ51526630.SGD","LU1712237335.SGD","LU2111349929.HKD","TMED","LU1069344957.HKD","RXL","LU0943347566.SGD","LU0122379950.USD","LU0316494557.USD","IE00B1XK9C88.USD","LU1623119135.USD","LU2361045086.USD","LU1551013425.SGD","LU0256863811.USD","SG9999001176.SGD","SG9999015978.USD","LU2756315664.SGD","LU1023059063.AUD","LU1057294990.SGD","SGXZ31699556.SGD","LU1814569148.SGD","BK4516","LLY","LU1093756325.SGD","LU1974910355.USD","PJP","IE0005OL40V9.USD","IE0009355771.USD","LU0471298777.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU0353189680.USD","LU1291159041.SGD","LU0823434583.USD","LU1868836757.USD","LU1720051108.HKD","LU2023250330.USD","LU2168564495.EUR","SGXZ99366536.SGD","IE00BJT1NW94.SGD","MHIP","LU0889565916.HKD","LU2108987350.USD","LU2468319806.SGD","LU0345770993.USD","LU0097036916.USD","LU2106854487.HKD","LU0114720955.EUR","LU2237443622.USD","LU2237443895.HKD","LU2361044865.SGD","LU2552382058.USD","IE00B4JS1V06.HKD","FTXH","LU1868837136.USD","BK4534","LU0158827781.USD","LU0094547139.USD","BK4533","LU1323610961.USD","BK4581","SG9999014898.SGD","LU2089284900.SGD","WDNA","LU2471134952.CNY","LU0672654240.SGD","LU2112291526.USD","LU2237443382.USD","LU0964807845.USD","XLV","SG9999001176.USD","LLYZ","LLII","IE00BJLML261.HKD","IE00BJJMRY28.SGD","LU2361044949.HKD","LU0417517546.SGD","LU0385154629.USD","TRUH","LU2168564222.USD","IYH","LU0345770308.USD","LU0096364046.USD","LU1691799644.USD","LU0471298694.HKD","IE0004445239.USD","LLYX","LU0466842654.USD","LU2264538146.SGD","LU1868837300.USD","LU0354030438.USD","LU2271345857.HKD","LU2087625088.SGD","LU0174119429.USD","LU2471134523.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0708995401.HKD","HRTS","SG9999018865.SGD","OZEM","LU2023251221.USD","LU0640476718.USD","LU0683600562.USD","LU1629891620.HKD","LU0353189763.USD","LU1983299246.USD","SG9999017495.SGD","SG9999014906.USD","IE00B775H168.HKD","LU1093756168.USD","IHE","IE00BJJMRX11.SGD","LU2324357040.USD","LU1868836914.USD","LU1989771016.USD","LU0225283273.USD","LU2471134879.HKD","LU2756315318.SGD","LU2462591350.SGD","LU1548497426.USD","ELIS","IE0004445015.USD","LU0061475181.USD","LU1035775433.USD","LU2491050154.USD","LU2746668974.SGD","SG9999018857.SGD","CANC","FHLC","IE00BK4W5M84.HKD","LU2089283258.USD","LU0320765059.SGD","SG9999014914.USD","BK4588","LU0234572021.USD","BK4599","LU0432979614.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU0820561909.HKD","LU0323591593.USD","LU1232071149.USD","LU2461242641.AUD","LU0109394709.USD","LU2063271972.USD","IE00BKPKM429.USD","IE00B2B36J28.USD","LU0203201768.USD","LU1988902786.USD","LU2602419157.SGD","LU0106261372.USD","LU2237443465.HKD","LU2552382215.SGD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0006306889.USD","CURE","IE00BJJMRZ35.SGD","LU2750360641.GBP","LU1061106388.HKD","AGNG","LU2360106947.USD","SG9999013999.USD","LU1127390331.HKD","LU0198837287.USD","LU0238689110.USD","LU1366192091.USD","LU2028103732.USD","LU2168564149.EUR","LU0820561818.USD","BK4585","LU0210536198.USD","LU0786609619.USD","GDOC","BK4007","IE0002141913.USD","MEDI","ILDR","LU2023250504.SGD","LU2491050071.SGD","LU1720051017.SGD","LU2236285917.USD","GB00BDT5M118.USD","LU2089984988.USD","LU0158827948.USD","LU2168564065.EUR","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168986397","title":"FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險","url":"https://stock-news.laohu8.com/highlight/detail?id=1168986397","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168986397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:02","pubTimestamp":1787914941,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准礼来旗下药物 Mounjaro的新适应症——用于降低伴有2型糖尿病的成年患者心血管事件风险。这一决定为众多糖尿病合并心血管高风险人群带来了新的治疗选项。此次获批标志着替尔泊肽在代谢与心血管交叉领域的又一重要进展。随着适应症范围的扩大，替尔泊肽的临床使用覆盖面将更加广泛，有望进一步重塑2型糖尿病合并心血管疾病患者的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2089984988.USD","LU2360106947.USD","LU1804176565.USD","LU2361044949.HKD","LU0964807845.USD","LU2461242641.AUD","LU2357305700.SGD","SGXZ81514606.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU2023250330.USD","IE00B7KXQ091.USD","LU0225283273.USD","LU2089284900.SGD","LU0266013472.USD","LU0672654240.SGD","LU2237443895.HKD","LU1023059063.AUD","SGXZ51526630.SGD","LU0158827781.USD","LU1974910355.USD","LU2602419157.SGD","LU0238689110.USD","LU0006306889.USD","LU2236285917.USD","IE0009355771.USD","LU2491050071.SGD","ELIL","LU2417539215.USD","LU0432979614.USD","IE00BJJMRX11.SGD","LU2491049909.HKD","PJP","LU2462591350.SGD","LU0708995401.HKD","LU2168563687.JPY","LU2750360641.GBP","SG9999014906.USD","LU0256863902.USD","LU0353189680.USD","LU0823416689.USD","IE00BK4W5L77.USD","LU2237443465.HKD","LU2265009873.SGD","LU2491050154.USD","TMED","LU2746668974.SGD","OZEM","LU0203202063.USD","LU0456855351.SGD","WDNA","LLYX","BK4007","LU0174119429.USD","LU2168564495.EUR","LU2361045086.USD","SG9999018857.SGD","LU0345770993.USD","LU0640476718.USD","LU1868837300.USD","IE00BWXC8680.SGD","LLY","LU1064131342.USD","LU0882574139.USD","LU0689472784.USD","LU2023251221.USD","VHT","BK4533","LU0256863811.USD","LU2264538146.SGD","LU2471134879.HKD","LU1145028129.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","MHIP","IE0004445239.USD","IE00BJLML261.HKD","BK4581","LU0122379950.USD","XLV","HRTS","LU1629891620.HKD","LU0385154629.USD","LU0096364046.USD","LU2552382058.USD","LU1551013425.SGD","LU1720051108.HKD","LU0079474960.USD","LLII","LU0158827948.USD","LU2756315318.SGD","LU0882574055.USD","LU0097036916.USD","IE0005OL40V9.USD","FTXH","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2896262040.SGD","LU2361044865.SGD","IE00BFSS8Q28.SGD","LU0234572021.USD","SG9999001176.USD","LU2237443978.SGD","LU0354030438.USD","CANC","LU0320765059.SGD","LU1267930730.SGD","SG9999014914.USD","MEDI","LU2063271972.USD","LU1917777945.USD","LU1093756325.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU1232071149.USD","IHE","LU1989771016.USD","GDOC","IYH","LU1093756168.USD","SG9999015986.USD","SG9999014898.SGD","LU0471298694.HKD","LU2471134796.USD","LU1057294990.SGD","LU0058720904.USD","LU1291159041.SGD","LU2023250504.SGD","LU2552382132.HKD","SG9999017495.SGD","IE00B4JS1V06.HKD","SG9999015978.USD","LU0417517546.SGD","LU1551013342.USD","JDOC","ELIS","LU1548497426.USD","THNR","LU1868836757.USD","IE00BJJMRY28.SGD","LU0786609619.USD","LU2237438978.USD","LU2471134523.USD","IE00BN29S564.USD","LU0289739699.SGD","LU0823434583.USD","IE00B2B36J28.USD","LU2213496289.HKD","TRUH","LU2028103732.USD","LU1323610961.USD","LU0345770308.USD","LU1061106388.HKD","LU2168564222.USD","LU0109394709.USD","BK4585","LU1868837136.USD","AGNG","LU0320765992.SGD","LU1988902786.USD","LU0353189763.USD","LU2468319806.SGD","SG9999015952.SGD","LU2089283258.USD","PPH","IE00BJT1NW94.SGD","LU0106261372.USD","LU0203201768.USD","LU1983299246.USD","SG9999013999.USD","LU1280957306.USD","LU0823434740.USD","LU0114720955.EUR","LU2746668461.USD","RXL","IE00B1XK9C88.USD","IE00B775H168.HKD","LU0323591593.USD","SG9999014880.SGD","LU1035775433.USD","LU1712237335.SGD","LU2108987350.USD","LU0943347566.SGD","LU2237443622.USD","LU1868836914.USD","LU2211815571.USD","LU1868836591.USD","LU0820561818.USD","BK4588","IXJ","ILDR","SG9999018865.SGD","LU2750360997.AUD","LU2271345857.HKD","LU0061475181.USD","LU2456880835.USD","LU0787776722.HKD","LU2324357040.USD","LU2168564149.EUR","LU0354030511.USD","LU2756315664.SGD","LU1814569148.SGD","SG9999001176.SGD","IE00BK4W5M84.HKD","IE0004445015.USD","LU0683600562.USD","LU0198837287.USD","LU2237443382.USD","LU2111349929.HKD","LU1979441026.SGD","LU0133085943.USD","BK4516","LU1366192091.USD","LU2462157665.USD","LU2112291526.USD","CURE","LU1691799644.USD","IE00BFSS7M15.SGD","LU2471134952.CNY","LU2087625088.SGD","GB00BDT5M118.USD","IE0002141913.USD","MEDX","SGXZ31699556.SGD","SGXZ99366536.SGD","LU0471298777.SGD","LU2106854487.HKD","LU0109391861.USD","FHLC","LU0210536198.USD","LU0466842654.USD","LU0094547139.USD","BK4599","LU2552382215.SGD","IE00B4R5TH58.HKD","LU1623119135.USD","SG9999015945.SGD","LLYZ","LU0316494557.USD","LU2237443549.SGD","IE0001KFT4U8.USD","LU1720051017.SGD","LU1127390331.HKD","LU0820562030.AUD","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662693000","title":"焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變","url":"https://stock-news.laohu8.com/highlight/detail?id=2662693000","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662693000?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911288,"startTime":"0","endTime":"0","summary":"焦点-超越体重：男性纷纷前往美容诊所，以实现减肥蜕变外科医生指出，社交媒体和不断变化的男性气概规范是男性美容需求日益增长的原因GoodRx数据显示，男性目前占减肥药使用者的28.3%医生预计，随着包括口服药在内的新型减肥药问世，需求将进一步增长Sriparna Roy路透8月28日-患者和整形外科医生表示，随着畅销减肥药帮助更多美国男性瘦身，越来越多的人正在寻求针对皮肤松弛、脱发和牙齿问题的美容治疗，以完成他们的身体蜕变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1548497426.USD","LU2168564065.EUR","IHE","LU1917777945.USD","LU0174119429.USD","GB00BDT5M118.USD","SG9999014906.USD","LU0238689110.USD","LU2357305700.SGD","LU0471298777.SGD","LLYZ","LU2237443895.HKD","LU2552382132.HKD","LU2023250330.USD","SG9999014880.SGD","LU1983299246.USD","LU1720051108.HKD","SG9999015986.USD","JDOC","LU1232071149.USD","LU2028103732.USD","IE00BJJMRZ35.SGD","BK4588","LU1093756168.USD","LU2213496289.HKD","LU1868836591.USD","LU1720051017.SGD","IE00BK4W5M84.HKD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1366192091.USD","LU2602419157.SGD","IYH","LU0256863902.USD","LU0158827781.USD","SG9999018865.SGD","TMED","PJP","LU2456880835.USD","LU2896262040.SGD","LU2746668461.USD","LU0320765059.SGD","NVOX","LU0323591593.USD","LU2462157665.USD","LU0964807845.USD","LU1814569148.SGD","LU0640476718.USD","AGNG","LLII","LU0823416689.USD","LU2168564495.EUR","LU2237443622.USD","LU0158827948.USD","LU0471298694.HKD","SG9999017495.SGD","LU0683600562.USD","LU1868837136.USD","LU0198837287.USD","LU2271345857.HKD","LU2361044865.SGD","LU2023250504.SGD","LU1989771016.USD","SGXZ51526630.SGD","WDNA","IE00BKVL7J92.USD","LU2089283258.USD","SG9999018857.SGD","LU2237443465.HKD","LU1323610961.USD","LU0345770993.USD","LU2462591350.SGD","PPH","LU0058720904.USD","LU1127390331.HKD","SGXZ57979304.SGD","SG9999001176.USD","LU0203202063.USD","IE00B1XK9C88.USD","LU1551013342.USD","LU1093756325.SGD","LU0097036916.USD","LU2552382215.SGD","LU1035775433.USD","LU0320765992.SGD","LU2265009873.SGD","LU2324357040.USD","LU2491049909.HKD","HRTS","LU0820561909.HKD","LU1145028129.USD","CURE","LU2168564222.USD","LU2264538146.SGD","LU2491050071.SGD","SG9999015945.SGD","LU0133085943.USD","LU0456855351.SGD","LU2168564149.EUR","LU0432979614.USD","LU1057294990.SGD","LU1023059063.AUD","LU0417517546.SGD","RXL","IE00BFSS7M15.SGD","LU0234572021.USD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU0266013472.USD","LU1291159041.SGD","LU0316494557.USD","LU2468319806.SGD","LU2237443549.SGD","LU0256863811.USD","LU1804176565.USD","LU2087625088.SGD","LU1267930730.SGD","LU2237443382.USD","LU0353189763.USD","LU2236285917.USD","SG9999015978.USD","LU2471134523.USD","THNR","IE00B775H168.HKD","IE00BKPKM429.USD","BK4585","SGXZ99366536.SGD","TRUH","LU0154236417.USD","IE00BK4W5L77.USD","LU2750360997.AUD","IE00B7KXQ091.USD","IE0009355771.USD","IXJ","LU0466842654.USD","LU0006306889.USD","LU0943347566.SGD","LLY","LLYX","ILDR","LU1868836757.USD","LU1979441026.SGD","SGXZ81514606.USD","SG9999001176.SGD","IE0004445015.USD","IE0004445239.USD","LU0122379950.USD","LU2089984988.USD","BK4599","VHT","LU0079474960.USD","LU2552382058.USD","LU1069344957.HKD","BK4581","LU2360106947.USD","LU0882574139.USD","LU0820561818.USD","LU2756315664.SGD","SG9999015952.SGD","LU0345770308.USD","LU1868837300.USD","LU2211815571.USD","ELIL","LU2746668974.SGD","LU0708995401.HKD","IE00B2B36J28.USD","LU0203201768.USD","LU2361044949.HKD","LU2361045086.USD","LU2461242641.AUD","LU0094547139.USD","LU1623119135.USD","LU2417539215.USD","MEDX","LU0823434740.USD","LU0225283273.USD","MHIP","BK4534","LU0096364046.USD","LU2750360641.GBP","LU0787776722.HKD","LU0689472784.USD","LU2471134952.CNY","BK4532","IE00B4R5TH58.HKD","NVOC","LU0109391861.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","LU1629891620.HKD","LU2491050154.USD","SGXZ31699556.SGD","LU0353189680.USD","OZEM","LU1064131342.USD","BK4007","NVOH","LU2471134879.HKD","LU0889565916.HKD","ELIS","GDOC","IE00BN29S564.USD","LU0882574055.USD","IE00B4JS1V06.HKD","LU0210536198.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU0820562030.AUD","IE0005OL40V9.USD","LU2237438978.USD","CANC","IE0002141913.USD","LU2023251221.USD","LU2063271972.USD","LU2106854487.HKD","LU0289739699.SGD","LU0109394709.USD","LU0061475181.USD","FHLC","LU1988902786.USD","BK4516","LU0823434583.USD","LU2112291526.USD","LU0385154629.USD","BK4533","XLV","IE00BJJMRX11.SGD","LU2089284900.SGD","LU1551013425.SGD","IE0001KFT4U8.USD","SG9999013999.USD","LU2237443978.SGD","SG9999014914.USD","IE00BWXC8680.SGD","LU0672654240.SGD","LU2168563687.JPY","LU2111349929.HKD","LU0786609619.USD","SG9999014898.SGD","LU1712237335.SGD","LU0354030511.USD","LU0106261372.USD","MEDI","LU2108987350.USD","LU2756315318.SGD","IE00BJLML261.HKD","NVO","LU0114720955.EUR","LU1974910355.USD","LU1691799644.USD","FTXH","LU2471134796.USD","IE00BFSS8Q28.SGD","IE00BZ1G4Q59.USD","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示，美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O，用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","IBB","GILD","IE00B19Z3581.USD","IBBQ","IE00B3T34201.USD","LU1934455194.USD","BK4532","IE00B7SZLL34.SGD","LU0965509283.SGD","BIB","IE00BKVL7J92.USD","LU0114720955.EUR","BK4566","LU1571399168.USD","LU2468319806.SGD","IE0002270589.USD","BMED","MEDI","LU0889565916.HKD","SG9999015945.SGD","IE00BZ1G4Q59.USD","BK4139","LU1066053197.SGD","LU1934455277.USD","TMED","LU0861579265.USD","LU2112291526.USD","LU1061106388.HKD","LU0109394709.USD","SG9999015952.SGD","LU0965508806.USD","LU0823416689.USD","LU0965509101.SGD","BBH","LU2324357040.USD","LU1023059063.AUD","SG9999015986.USD","LU0058720904.USD","LU1778281490.HKD","TBXU","LU1037948541.HKD","LU0289739699.SGD","LU1037948897.HKD","SG9999015978.USD","BK4585","BK4568","LU1839511570.USD","LU1430594728.SGD","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂，专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患，也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现，将给药频率与用药负担同步压缩，患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BBH","LU1934455277.USD","LU0289739699.SGD","LU2468319806.SGD","IE0002270589.USD","BK4583","TBXU","LU0058720904.USD","LU1571399168.USD","LU0859254822.USD","SG9999015978.USD","LU1430594728.SGD","LU2357627491.SGD","LU1585245621.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0122379950.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2087621335.USD","TMED","SG9999015986.USD","IE00BKVL7J92.USD","LU2112291526.USD","LU0889565916.HKD","LU1023059063.AUD","LU0882574055.USD","LU1674673428.USD","MEDI","LU0109394709.USD","LU1066053197.SGD","LU1839511570.USD","LU1061106388.HKD","SG9999015945.SGD","BK4578","GILD","IBBQ","LU0965509283.SGD","LU1674673691.USD","IBB","LU0114720955.EUR","LU0320765992.SGD","SG9999015952.SGD","IE00B7SZLL34.SGD","LU0965508806.USD","LU1778281490.HKD","LU1934455194.USD","LU0234570918.USD","BK4588","LU0823416689.USD","BIB","BK4550","BK4532","BK4585","BMED","LU0965509010.AUD","LU1037948897.HKD","IE00B3T34201.USD","LU1057294990.SGD","LU2324357040.USD","BK4139","BK4568","LU1934455863.HKD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677565","title":"兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677565?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:41","pubTimestamp":1787812915,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2471134952.CNY","LU1127390331.HKD","LU2108987350.USD","LU0079474960.USD","OZEM","LU2213496289.HKD","LU0820561818.USD","LU2456880835.USD","SGXZ99366536.SGD","FHLC","BK4532","IYH","LU0266013472.USD","LU1917777945.USD","LU2168564065.EUR","LU0353189680.USD","LU0058720904.USD","LU0345770308.USD","LU0198837287.USD","LU0354030511.USD","LU2471134796.USD","NVOX","LU0354030438.USD","SG9999014898.SGD","LU0471298777.SGD","RXL","IE00B7KXQ091.USD","LU0174119429.USD","LU2746668461.USD","IE00BN29S564.USD","LU1979441026.SGD","LU2063271972.USD","LU1023059063.AUD","IE00B1BXHZ80.USD","SG9999015945.SGD","LU2357305700.SGD","LU2237443465.HKD","LU2324357040.USD","LU2237443895.HKD","LU0417517546.SGD","LU2746668974.SGD","GDOC","LU0106261372.USD","MHIP","SG9999015978.USD","LU0316494557.USD","LU0889565916.HKD","LU0964807845.USD","LU1814569148.SGD","LLYZ","LU0109391861.USD","LU2168564495.EUR","LU1232071149.USD","LU2750360641.GBP","LU0820562030.AUD","LU2756315664.SGD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1323610961.USD","LU1868837300.USD","LU0114720955.EUR","IHE","LU1623119135.USD","LU2360106947.USD","LU2461242641.AUD","SG9999018865.SGD","LU0689472784.USD","LU1868836914.USD","BK4533","LU2471134523.USD","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","SG9999018857.SGD","LU2237443382.USD","LU1989771016.USD","IE0009355771.USD","LU1983299246.USD","LU2237443622.USD","AGNG","IE00B4R5TH58.HKD","LU1145028129.USD","LU0061475181.USD","LU0385154629.USD","LU2462157665.USD","LU1988902786.USD","LU1064131342.USD","IE00B4JS1V06.HKD","VHT","LU1720051108.HKD","LU2552382215.SGD","LU2023251221.USD","IE00BKPKM429.USD","HRTS","NVOC","BK4581","LU2236285917.USD","LU1267930730.SGD","LU0006306889.USD","LU1720051017.SGD","LU1551013425.SGD","LU2264538146.SGD","LU0094547139.USD","TMED","LU2023250504.SGD","LU0256863902.USD","SG9999015952.SGD","LU0353189763.USD","LU0097036916.USD","LU2462591350.SGD","LU0238689110.USD","SG9999013999.USD","BK4007","IE00BFSS7M15.SGD","LU2468319806.SGD","LU0133085943.USD","LU1069344957.HKD","LU0122379950.USD","LU2211815571.USD","WDNA","LU2361044865.SGD","LU0154236417.USD","LU1691799644.USD","LU2112291526.USD","LU2028103732.USD","LU2237438978.USD","SG9999014880.SGD","LLYX","LU0882574139.USD","LU2361045086.USD","XLV","LU0158827781.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0158827948.USD","LU2237443978.SGD","LU2087625088.SGD","CURE","LU1093756325.SGD","LU2237443549.SGD","LU0471298694.HKD","LU0672654240.SGD","LU0943347566.SGD","MEDX","LU1057294990.SGD","PPH","LU1868836757.USD","SG9999001176.SGD","LU2089284900.SGD","ILDR","LU2361044949.HKD","IE00BKVL7J92.USD","LU0320765059.SGD","THNR","BK4516","LU2552382132.HKD","LU1061106388.HKD","ELIL","LU2491049909.HKD","NVOH","LU0820561909.HKD","LU2168564149.EUR","LU0787776722.HKD","IE00BJJMRZ35.SGD","IE00BKDWB100.SGD","LU0109394709.USD","LU1280957306.USD","IE00B1XK9C88.USD","LU0786609619.USD","IE0002141913.USD","SGXZ31699556.SGD","LU2471134879.HKD","SG9999017495.SGD","SGXZ51526630.SGD","FTXH","LU0203202063.USD","LU2896262040.SGD","LU2168563687.JPY","LU0466842654.USD","LU2265009873.SGD","IXJ","LU0683600562.USD","IE0001KFT4U8.USD","LU0210536198.USD","IE00BK4W5L77.USD","LU0234572021.USD","LU1551013342.USD","LU1712237335.SGD","LU2168564222.USD","JDOC","LU2111349929.HKD","LU1291159041.SGD","LU1366192091.USD","LU0708995401.HKD","LU2089984988.USD","SG9999001176.USD","LU0345770993.USD","LU0823416689.USD","LU2106854487.HKD","SGXZ81514606.USD","IE0004445239.USD","IE00BK4W5M84.HKD","ELIS","LU1093756168.USD","LU2271345857.HKD","LU1804176565.USD","IE00BZ1G4Q59.USD","SGXZ57979304.SGD","NVO","BK4599","LU1868836591.USD","LU2417539215.USD","LU2491050154.USD","GB00BDT5M118.USD","IE0005OL40V9.USD","LU0432979614.USD","PJP","LLY","LU0882574055.USD","LU2023250330.USD","LU2750360997.AUD","SG9999014914.USD","CANC","IE00BWXC8680.SGD","LU1548497426.USD","LU0823434583.USD","LU0096364046.USD","LU2552382058.USD","IE00BJLML261.HKD","LU1035775433.USD","LU1868837136.USD","LU2756315318.SGD","BK4534","LU0289739699.SGD","LU0323591593.USD","LU0203201768.USD","LU0823434740.USD","LLII","LU1629891620.HKD","LU2491050071.SGD","MEDI","IE0004445015.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU0456855351.SGD","LU0640476718.USD","BK4585","IE00BJJMRY28.SGD","SG9999014906.USD","LU2602419157.SGD","SG9999015986.USD","LU2089283258.USD","TRUH","LU0256863811.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}